IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0142550.html
   My bibliography  Save this article

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda

Author

Listed:
  • Solomon J Lubinga
  • Esther C Atukunda
  • George Wasswa-Ssalongo
  • Joseph B Babigumira

Abstract

Background: In settings where home birth rates are high, prenatal distribution of misoprostol has been advocated as a strategy to increase access to uterotonics during the third stage of labor to prevent postpartum hemorrhage (PPH). Our objective was to project the potential cost-effectiveness of this strategy in Uganda from both governmental (the relevant payer) and modified societal perspectives. Methods and Findings: To compare prenatal misoprostol distribution to status quo (no misoprostol distribution), we developed a decision analytic model that tracked the delivery pathways of a cohort of pregnant women from the prenatal period, labor to delivery without complications or delivery with PPH, and successful treatment or death. Delivery pathway parameters were derived from the Uganda Demographic and Health Survey. Incidence of PPH, treatment efficacy, adverse event and case fatality rates, access to misoprostol, and health resource use and cost data were obtained from published literature and supplemented with expert opinion where necessary. We computed the expected incidence of PPH, mortality, disability adjusted life years (DALYs), costs and incremental cost effectiveness ratios (ICERs). We conducted univariate and probabilistic sensitivity analyses to examine robustness of our results. In the base-case analysis, misoprostol distribution lowered the expected incidence of PPH by 1.0% (95% credibility interval (CrI): 0.55%, 1.95%), mortality by 0.08% (95% CrI: 0.04%, 0.13%) and DALYs by 0.02 (95% CrI: 0.01, 0.03). Mean costs were higher with prenatal misoprostol distribution from governmental by US$3.3 (95% CrI: 2.1, 4.2) and modified societal (by US$1.3; 95% CrI: -1.6, 2.8) perspectives. ICERs were US$191 (95% CrI: 82, 443) per DALY averted from a governmental perspective, and US$73 (95% CI: -86, 256) per DALY averted from a modified societal perspective. Conclusions: Prenatal distribution of misoprostol is potentially cost-effective in Uganda and should be considered for national-level scale up for prevention of PPH.

Suggested Citation

  • Solomon J Lubinga & Esther C Atukunda & George Wasswa-Ssalongo & Joseph B Babigumira, 2015. "Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-21, November.
    • Handle: RePEc:plo:pone00:0142550
    DOI: 10.1371/journal.pone.0142550
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142550
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0142550&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0142550?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Radha Rajasingham & Melissa A Rolfes & Kate E Birkenkamp & David B Meya & David R Boulware, 2012. "Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis," PLOS Medicine, Public Library of Science, vol. 9(9), pages 1-10, September.
    2. Stéphane Verguet & Ramanan Laxminarayan & Dean T. Jamison, 2015. "Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost‐Effectiveness Analysis," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 318-332, March.
    3. Joseph B Babigumira & Andy Stergachis & David L Veenstra & Jacqueline S Gardner & Joseph Ngonzi & Peter Mukasa-Kivunike & Louis P Garrison, 2012. "Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Simon P S Kibira & Christine Muhumuza & Justine N Bukenya & Lynn M Atuyambe, 2015. "“I Spent a Full Month Bleeding, I Thought I Was Going to Die…” A Qualitative Study of Experiences of Women Using Modern Contraception in Wakiso District, Uganda," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-13, November.
    2. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
    3. Hampson, G. & Towse, A. & Henshall, C., 2017. "Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies," Briefings 001835, Office of Health Economics.
    4. Andrew Briggs & Rachel Nugent, 2016. "Editorial," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 6-8, February.
    5. Neily Zakiyah & Antoinette D I van Asselt & Frank Roijmans & Maarten J Postma, 2016. "Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-19, December.
    6. Driessen, Julia & Olson, Zachary D. & Jamison, Dean T. & Verguet, Stéphane, 2015. "Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis," Social Science & Medicine, Elsevier, vol. 139(C), pages 115-122.
    7. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
    8. Jessica Ochalek & Karl Claxton & Paul Revill & Mark Sculpher & Alexandra Rollinger, 2016. "Supporting the development of an essential health package: principles and initial assessment for Malawi," Working Papers 136cherp, Centre for Health Economics, University of York.
    9. Salti, Nisreen & Brouwer, Elizabeth & Verguet, Stéphane, 2016. "The health, financial and distributional consequences of increases in the tobacco excise tax among smokers in Lebanon," Social Science & Medicine, Elsevier, vol. 170(C), pages 161-169.
    10. Deidda, Manuela & Geue, Claudia & Kreif, Noemi & Dundas, Ruth & McIntosh, Emma, 2019. "A framework for conducting economic evaluations alongside natural experiments," Social Science & Medicine, Elsevier, vol. 220(C), pages 353-361.
    11. Katherine T. Lofgren & David A. Watkins & Solomon T. Memirie & Joshua A. Salomon & Stéphane Verguet, 2021. "Balancing health and financial protection in health benefit package design," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 3236-3247, December.
    12. Junnan Jiang & Henry Lucas & Qian Long & Yanjiao Xin & Li Xiang & Shenglan Tang, 2019. "The Effect of an Innovative Financing and Payment Model for Tuberculosis Patients on Health Service Utilization in China: Evidence from Hubei Province of China," IJERPH, MDPI, vol. 16(14), pages 1-15, July.
    13. Enden, M.R. & Tolla, M.T. & Norheim, O.F., 2021. "Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia," Social Science & Medicine, Elsevier, vol. 281(C).
    14. Özlem Karsu & Alec Morton, 2021. "Trading off health and financial protection benefits with multiobjective optimization," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 55-69, January.
    15. Admassu N. Lamu & Ole F. Norheim & Fredrik A. Gregersen & Mathias Barra, 2021. "Cycle‐network expansion plan in Oslo: Modeling cost‐effectiveness analysis and health equity impact," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 3220-3235, December.
    16. Okunade, Albert A. & Osmani, Ahmad Reshad, 2018. "Technology, Productivity, and Costs in Healthcare," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, pages 1-21.
    17. World Bank Group, 2018. "An Extended Cost-Effectiveness Analysis of Tobacco Price Increases in the Kyrgyz Republic," World Bank Publications - Reports 29819, The World Bank Group.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0142550. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.